@article{Iermak_Dunaieva_Ryndina_2017, title={Zofenopri’s and enalapril’s influence as part of standard therapy on the dynamics of copeptin, MRproADM, troponin I and indicators of cardiohemodynamics and lipid profile in patients with acute myocardial infarction with concomitant obesity }, volume={59}, url={https://www.jpep.endocrinology.org.ua/index.php/1/article/view/334}, DOI={10.21856/j-PEP.2017.1.02}, abstractNote={<p>It were examined 75 patients with acute myocardial infarction (AMI) and obesity, among which 37 patients received enalapril and 38 patients received zofenopril as part of standart therapy. According to received results enalapril’s and zofenopril’s using showed expressive positive effect on the parametrs of cardiohaemodynamic, lipid profil, copeptin, MRproADM, troponin I, systolic blood pressure and diastolic blood pressure in patients with acute myocardial infarction and obesity. The most significant changes revealed in group of zofenopril in the treatment of patients with acute myocardial infarction and obesity.</p>}, number={1}, journal={Problems of Endocrine Pathology}, author={Iermak, A. S. and Dunaieva, I. P. and Ryndina, N. G.}, year={2017}, month={Feb.}, pages={18-24} }